<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04544579</url>
  </required_header>
  <id_info>
    <org_study_id>https://orcid.org/0000-0002-07</org_study_id>
    <nct_id>NCT04544579</nct_id>
  </id_info>
  <brief_title>Endovascular Graft Anchoring Different Regions of Ascending Aorta in the Treatment of Ascending Aortic Dissection</brief_title>
  <official_title>Endovascular Graft Anchoring Different Regions of Ascending Aorta in the Treatment of Ascending Aortic Dissection: a Prospective， Controlled and Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Medical Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese Medical Association</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aortic dissection is a deadly and dangerous disease. About 28% of patients with ascending&#xD;
      aortic dissection can't tolerate open surgical trauma caused by thoracotomy and&#xD;
      cardiopulmonary bypass, and the prognosis is poor. Minimally invasive endovascular treatment&#xD;
      has been applied in the treatment of descending aortic dissection. However, due to the&#xD;
      special anatomical structure and high speed /pressure blood flow, the treatment of ascending&#xD;
      aorta dissection has become an international difficulty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was designed combination of retrospective and prospective methods, and focused on&#xD;
      distal false lumen Aneurysmal Expansion of Aortic Dissection (DAEAD) . To formulate clinical&#xD;
      data for the risk assessment of DAEAD, and best intracavitary treatment or long-term efficacy&#xD;
      evaluation, we combined the results of genetic testing, evaluating the missense mutation,&#xD;
      computer simulation of blood flow dynamics analysis, and clinical imaging analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>success of operation</measure>
    <time_frame>before December 2022</time_frame>
    <description>The operation was completed successfully without complications.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Ascending Aortic Dissection</condition>
  <arm_group>
    <arm_group_label>Ascending aortic dissection patients</arm_group_label>
    <description>Ascending aortic dissection patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stent grafts anchored in different areas</intervention_name>
    <description>Endovascular repair of ascending aortic dissection patients with stent grafts anchored in different areas</description>
    <arm_group_label>Ascending aortic dissection patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This clinical trial included a prospective study of patients admitted to the hospital with&#xD;
        aortic dissection between October 2020 and September 2023 who were treated with an&#xD;
        endoluminal graft after exclusion of surgical contraindications.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aortic dissection diagnosed by CTA;&#xD;
&#xD;
          -  With indications for endovascular treatment&#xD;
&#xD;
          -  The luminal graft anchor is required to be located in the ascending aorta.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Import difficult, such as external iliac artery diameter is less than 6 mm bilateral&#xD;
             iliac, artery stenosis distortions;&#xD;
&#xD;
          -  Patients with severe comorbidities, such as severe myocardial insufficient blood&#xD;
             supply, heart failure, arrhythmia, severe renal dysfunction, and severe blood&#xD;
             coagulation dysfunction;&#xD;
&#xD;
          -  Patients with malignant tumor, or other serious illness, life expectancy of less than&#xD;
             1 year；&#xD;
&#xD;
          -  Puncture local infection and high fever;⑤ within 1 month of the large area;&#xD;
&#xD;
          -  Contrast media in patients with cerebrovascular accident or digestive tract hemorrhage&#xD;
             patients with allergies;&#xD;
&#xD;
          -  Aortic ulcer or aortic wall hematoma and other atypical dissection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zaiping Jing, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vascular surgery, Changhai Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zaiping Jing, professor</last_name>
    <phone>02131161670</phone>
    <email>xueguanky@163.com</email>
  </overall_contact>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>September 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2020</study_first_posted>
  <last_update_submitted>September 3, 2020</last_update_submitted>
  <last_update_submitted_qc>September 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Medical Association</investigator_affiliation>
    <investigator_full_name>Zaiping Jing</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm, Dissecting</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

